• Users Online: 383
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2019  |  Volume : 16  |  Issue : 2  |  Page : 145-149

Vitamin D supplementation in the first trimester of pregnancy as an intervention to protect against adverse gestational outcomes in the third trimester


1 Department of Obstetrics and Gynecology, Medical College, Duhok University, Kurdistan Region, Iraq
2 Department of Medical Lab Technology, Shekhan Technical College of Health, Duhok Polytechnic University, Duhok, Kurdistan Region, Iraq

Correspondence Address:
Banav Najeeb Muhammed
Department of Gynecology and Obstetrics, Medical College, Duhok University, Kurdistan Region
Iraq
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/MJBL.MJBL_23_19

Get Permissions

Background: Vitamin D deficiency (VDD) is thought to be common among pregnant women and is a widespread public health problem. Objective: The aim of this study was to know whether the correction of VDD by Vitamin D supplementation given to pregnant women in the first trimester of pregnancy can prevent the development of complications such as preeclampsia (PE), gestational diabetes mellitus (GDM), and small for gestational age (SGA) in the third trimester or not, in a sample of pregnant women. Materials and Methods: The study was an experimental design. It was carried out between December 2016 and October 2018. A total 200 healthy pregnant women were included. They were chosen randomly in the first trimester of pregnancy from the Outpatient Clinic in Duhok Governorate of Kurdistan Region, Iraq. A knowledge questionnaire was used to collect information. Blood samples were taken and analyzed for the determination of 25 hydroxyvitamin D (25[OH] D). We did routine investigations which done for every pregnant woman as a part of antenatal care in the form of complete blood count, general urine examination, random blood sugar, and ultrasound. Results: Mean serum 25[OH] D concentration before supplementation was 8.41 ± 2.48 and after supplementation was 30.96 ± 9.60. There was a reduction in the risk of GDM and SGA but no change in the risk of PE. Conclusion: Supplementation of Vitamin D to pregnant women with VDD in the first trimester may lower the risk of GDM and SGA, but its effects in the prevention of PE need further evaluation. All patients had response to the Vitamin D supplement within 8–10 weeks regardless the outcomes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed202    
    Printed38    
    Emailed0    
    PDF Downloaded34    
    Comments [Add]    

Recommend this journal